Osaic Holdings
TXMD icon

Osaic Holdings’s TherapeuticsMD TXMD Stock Holding History

Osaic Holdings’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.41K Sell
690
-14,508
-95% -$30.3K ﹤0.01% 7438
2026
Q2 		$33.6K Buy
15,198
+15,045
+9,833% +$31.1K ﹤0.01% 5775
2026
Q1 		$308 Sell
153
-9,144
-98% -$20.6K ﹤0.01% 7509
2025
Q4 		$15.2K Buy
9,297
+8,400
+936% +$12.1K ﹤0.01% 6050
2025
Q3 		$972 Buy
897
+36
+4% +$40 ﹤0.01% 7367
2025
Q2 		$982 Buy
861
+11
+1% +$13 ﹤0.01% 7152
2025
Q1 		$788 Buy
850
+830
+4,150% +$827 ﹤0.01% 6889
2024
Q4 		$17 Sell
20
-36
-64% -$51 ﹤0.01% 7333
2024
Q3 		$92 Hold
56
– – ﹤0.01% 7253
2024
Q2 		$90 Sell
56
-980
-95% -$1.98K ﹤0.01% 7259
2024
Q1 		$2.37K Buy
1,036
+1,000
+2,778% +$2.32K ﹤0.01% 6407
2023
Q4 		$81 Sell
36
-215
-86% -$519 ﹤0.01% 7131
2023
Q3 		$756 Sell
251
-3,286
-93% -$12.4K ﹤0.01% 6906
2023
Q2 		$14.6K Buy
3,537
+3,020
+584% +$11.8K ﹤0.01% 5756
2023
Q1 		$1.94K Hold
517
– – ﹤0.01% 6725
2022
Q4 		$3.11K Buy
517
+15
+3% +$88 ﹤0.01% 6468
2022
Q3 		$4K Buy
502
+75
+18% +$607 ﹤0.01% 6525
2022
Q2 		$4K Sell
427
-92
-18% -$879 ﹤0.01% 6634
2022
Q1 		$1.76M Sell
519
-6
-1% -$94 ﹤0.01% 2031
2021
Q4 		$9K Sell
525
-60
-10% -$1.8K ﹤0.01% 6354
2021
Q3 		$20K Buy
585
+360
+160% +$16K ﹤0.01% 5782
2021
Q2 		$13K Sell
225
-1
-0.4% -$61 ﹤0.01% 5919
2021
Q1 		$15K Buy
226
+9
+4% +$705 ﹤0.01% 5659
2020
Q4 		$13K Sell
217
-405
-65% -$27.7K ﹤0.01% 5412
2020
Q3 		$49K Buy
622
+74
+14% +$5.9K ﹤0.01% 4320
2020
Q2 		$33K Sell
548
-561
-51% -$32.7K ﹤0.01% 4477
2020
Q1 		$59K Buy
+1,109
New +$110K ﹤0.01% 3866

Other funds holding TXMD

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Tejara Capital
Tejara Capital London, United Kingdom $205M AUM 0.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Osaic Holdings's TXMD Position: Q3 2026 in Review

Osaic Holdings reduced its TherapeuticsMD (TXMD) stake by 95% in Q3 2026, selling an estimated $30.3K and leaving 690 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #7438.

Osaic Holdings first reported a position in TXMD in Q1 2020 and has held it in 27 quarters since. The position peaked at $1.76M in Q1 2022. 36 funds tracked by Wall St. Rank hold TXMD as of Q3 2026.

  • Osaic Holdings held 690 shares of TherapeuticsMD worth $1.41K as of Q3 2026.
  • Osaic Holdings sold 14,508 TherapeuticsMD shares in Q3 2026, an estimated $30.3K.
  • TherapeuticsMD made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7438 holding.
  • Osaic Holdings first reported a position in TherapeuticsMD in Q1 2020 and has held it in 27 quarters since.
  • Osaic Holdings's TherapeuticsMD position peaked at $1.76M in Q1 2022.
  • 36 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.